Clinical Trial Update: Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ [Phase 3]

View source ↗

Summary

Phase 3 trial comparing radiotherapy to low-dose tamoxifen after breast-conserving surgery for low-risk breast ductal carcinoma in situ (DCIS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Ductal Carcinoma in Situ

Drugs mentioned

• Low-dose tamoxifen (tamoxifen)
• Radiotherapy

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Breast Ductal Carcinoma in Situ | Phase 3 | Status: UNKNOWN